Skip to main content
SpringerLink
Log in

The immunogenicity and safety of a new combined diphtheria, tetanus and poliomyelitis booster vaccine (Td-eIPV)

  • Addendum
  • Published:
Infection Aims and scope Submit manuscript

Summary

In view of the continuing risk of contracting tetanus, diphtheria and poliomyelitis, and the well-documented decline in immunity with time, the need for booster vaccinations is substantial. The immunogenicity and safety of a new combined booster vaccine against tetanus, diphtheria and poliomyelitis (REVAXIS™) developed by Pasteur Mérieux Connaught (Lyon, France) were evaluated in four clinical studies. This vaccine (Td-eIPV) combines an adsorbed tetanus toxoid and low-dose diphtheria toxoid vaccine (Td) with an enhanced, inactivated polio vaccine against poliovirus types 1, 2 and 3 (eIPV). In 256 healthy young adults, a single dose of Td-eIPV was shown to be immunogenic, eliciting antibody levels considered protective against disease for each vaccine component in ≥99.6% of the subjects. In 112 healthy older subjects (>40 years of age), two doses of Td-eIPV elicited seroprotective levels of antibodies in 94% of the subjects for diphtheria, and in all subjects for tetanus and poliovirus types 1, 2 and 3. Safety data from all 368 subjects, as well as 31 phase I volunteers and 1,742 subjects included in a safety study, reveal that the vaccine is safe. Most reactions were predictable, temporary and mild. There was no evidence that the vaccine was associated with any clinically serious event or modification of clinical laboratory parameters. The data reviewed here show that Td-eIPV is immunogenic and safe when administered as a booster vaccination in healthy adults of all ages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Edwards, K. M.: Diphtheria, tetanus and pertussis immunisations in adults. Infect. Dis. Clin. North Am. 4 (1990) 85–103.

    PubMed  CAS  Google Scholar 

  2. Miller, L.W., Older, J. J., Drake, J., Zimmerman, S.: Diphtheria immunization: effect upon carriers and the control of outbreaks. Am. J. Dis. Child 123 (1972) 197–199.

    PubMed  CAS  Google Scholar 

  3. Pappenheimer, A. M. J., Harper, A. A., Moynihan, M., Brockes, J. P.: Diphtheria toxin and related proteins: effect of route of injection on toxicity and the determination of cytotoxicity for various cultured cells. J. Infect. Dis. 145 (1982) 94–102.

    PubMed  CAS  Google Scholar 

  4. Pappenheimer, A. M. J.: Diphtheria: studies on the biology of an infectious disease. The Harvey Lectures. San Diego Academic Press, San Diego, 1982, pp. 45–73.

    Google Scholar 

  5. Galazka, A. M., Robertson, S. E., Oblapenko, G. P.: Resurgence of diphtheria. Eur. J. Epidemiol. 11 (1995) 95–105.

    Article  PubMed  CAS  Google Scholar 

  6. Galazka, A. M., Keja, J.: Diphtheria: incidence,trends and agewise changes of immunity. Scand. J. Infect. Dis. 20 (1988) 355–356.

    PubMed  CAS  Google Scholar 

  7. Galazka, A. M.: The immunological basis for immunisation series. Module 2: Diphtheria. WHO/EPI/GEN, Geneva 1993, p. 12.

    Google Scholar 

  8. Cellesi, C., Zanchi, A., Michelangeli, C., Giavannoni, F., Sansoni, A., Rossollini, G. M.: Immunity to diphtheria in a sample of adult population from northern Italy. Vaccine 7 (1989) 417–420.

    Article  PubMed  CAS  Google Scholar 

  9. Christenson, B., Bottiger, M.: Serological immunity to diphtheria in Sweden in 1978 and 1984. Scand. J. Infect. Dis. 18 (1986) 227–233.

    PubMed  CAS  Google Scholar 

  10. Cohen, D., Green, M., Katzenelson, E., Slepon, R., Bercovier, H., Wiener, M.: Long-term persistence of anti-diphtheria toxin antibodies among adults in Israel. Eur. J. Epidemiol. 10 (1974) 267–270.

    Article  Google Scholar 

  11. Comodo, N., Bonanni, P. K., Lo Nostro, A., Tiscione, E., Manelli, F., Tomei, A.: Low prevalence of diphtheria immunity in the population of Florence, Italy. Eur. J. Immunol. 12 (1996) 251–255.

    CAS  Google Scholar 

  12. Gupta, C. K., Griffin, P., Xu, J., Rivera, R., Thompson, C., Siber, G. R.: Diphtheria antitoxin level in US blood and plasma donors. J. Infect. Dis 173 (1996) 1493–1497.

    PubMed  CAS  Google Scholar 

  13. Kerttula, Y., Nors, T., Kuronen, T., Turpeinen, T.: Immunity to diphtheria in Helsinki in 1975. Scand. J. Infect. Dis. 12 (1980) 37–39.

    PubMed  CAS  Google Scholar 

  14. Kjeldsen, K., Simonsen, O., Heron, I.: Immunity against diphtheria and tetanus in the age group 30–70 years. Scand. J. Infect. Dis. 20 (1988) 177–185.

    PubMed  CAS  Google Scholar 

  15. Kjeldsen, K., Simonsen, O., Heron, I.: Immunity against diphtheria 25–30 years after primary vaccination in childhood. Lancet i (1985) 900–902.

    Article  Google Scholar 

  16. Klouche, M., Luhmann, D., Kirchener, H.: Low prevalence of diphtheria antitoxin in children and adults in northern Germany. Eur. J. Clin. Microbiol. Infect. Dis 14 (1995) 682–685.

    Article  PubMed  CAS  Google Scholar 

  17. Masterton, R. G., Tettmar, R. E., Pile, R. L. C., Jones, J., Croft, K. F.: Immunity to diphtheria in young British adults. J. Infect. 15 (1987) 27–32.

    Article  PubMed  CAS  Google Scholar 

  18. Organisation Mondiale de Santé: Vaccination des adultes contre la diphthérie. Relevé Epidémiol. Hebdo. 8 (1995) 56–58.

    Google Scholar 

  19. Rappuoli, R., Podda, A., Giovannoni, F., Nencioni, L., Peragallo, M., Francolini, P.: Absence of protective immunity against diphtheria in a large proportion of young adults. Vaccine 11 (1993) 576–577.

    Article  PubMed  CAS  Google Scholar 

  20. Sargent, I.: Diphtheria immunity in Massachusetts—a study of 3 urban patient populations. Am. J. Med. Sci. 287 (1984) 37–39.

    Article  PubMed  CAS  Google Scholar 

  21. Simonsen, O., Kjeldsen, K., Bentzon, M.W., Heron, I.: Susceptibility to diphtheria in populations vaccinated before and after elimination of indigenous diphtheria in Denmark. A comparative study of antitoxic immunity. Acta Pathol. Microbiol. Immunol. Scand. 95 (1987) 225–231.

    CAS  Google Scholar 

  22. Weiss, B. P., Strasburg, M. A., Feeley, J. C.: Tetanus and diphtheria immunity in an elderly population in LosAngeles Country Am. J. Pub. Health 73 (1983) 802–804.

    Article  PubMed  CAS  Google Scholar 

  23. Wirz, M., Puccinelli, M., Mele, C., Gentili, G.: Immunity to diphtheria in the 4-70-year age group in Italy. Vaccine 13 (1995) 771–773.

    Article  PubMed  CAS  Google Scholar 

  24. Vincent-Ballereau, F., Schrive, I., Fisch, A., Laurichesse, H., Romasko, C., Baron, D., Dublanchet, A., Deteix, P., Rey, M.: Immunité antidiphtérique de la population française adulte d'après une enquête sérologique multicentrique. Bull. Epidémiol. Hebdo. 15 (1995) 65–66.

    Google Scholar 

  25. Galazka, A., Robertson, S.E.: Diphtheria: changing patterns in the developing world and the industrialized world. Eur. J. Epidemiol. 11 (1995) 107–117.

    Article  PubMed  CAS  Google Scholar 

  26. Bjorkholm, B., Olling, S., Larsson, P., Hagberg, L.: An outbreak of diphtheria among Swedish alcoholics. Infection 15 (1987) 354–358.

    Article  PubMed  CAS  Google Scholar 

  27. Bjorkholm, B., Bottiger, M., Christenson, B., Hagberg, L.: Antitoxin antibody levels and the outcome of illness during an outbreak of diphtheria among alcoholics. Scand. J. Infect. Dis. 18 (1986) 235–239.

    PubMed  CAS  Google Scholar 

  28. Hardy, I. R. B., Dittmann, S., Sutter, R. W.: Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet 347 (1996) 1739–1744.

    Article  PubMed  CAS  Google Scholar 

  29. Organisation Mondiale de Santé Epidemie de diphtérie dans les états nouvellement indépendants de l'ex-URSS, Janvier 1995-Mars 1996. Relevé Epidémiol. Hebdo. 71 (1996) 245–250.

    Google Scholar 

  30. Organisation Mondiale de Santé: Epidémie de diphtéric dans les états nouvellement indépendants de l'ex-URSS 1900–1994. Relevé Epidémiol. Hebdo. 70 (1995) 141–144.

    Google Scholar 

  31. Christenson, B., Bottiger, M.: Epidemiology and immunity to tetanus in Sweden. Scand. J. Infect. Dis. 19 (1987) 429–435.

    PubMed  CAS  Google Scholar 

  32. Lackmann, G. M.: Tetanus immunity in young German adults. Presse Méd. 24 (1995) 960.

    PubMed  CAS  Google Scholar 

  33. Saliou, P., Relyveld, E. H., Marie, F. N., Le Cam, N., Coursaget, P.: Comparison of the results of field trials using various assessment methods for estimation of circulating tetanus antibody levels. In:Nistico, G., Bizzini, B., Bytchenko, B., Triau, R. (eds.): 8th International Conference on Tetanus. Pythagora Press, Rome, Milan 1989, pp. 267–273.

    Google Scholar 

  34. Steger, M. M., Maczek, C., Berger, P., Grubeck-Loebenstein, B.: Vaccination against tetanus in the elderly: do recommended vaccination strategies give adequate protection?. Lancet 348 (1996) 762.

    Article  PubMed  CAS  Google Scholar 

  35. Viljanen, M., Nieminen, S.: Immunity to tetanus in Finland. Scand. J. Infect. Dis. 12 (1980) 211–213.

    PubMed  CAS  Google Scholar 

  36. Malvy, D., Fuchs, F., Dubois, F., Roure, C., Aymard, M., Drucker, J.: Enquête séroépidemiologique de la poliomyélite dans six départements du centre ouest de la France. Med. Mal. Infect. 26 (1996) 714–720.

    Article  Google Scholar 

  37. Oostvogel, P. M., van Wijngaarden, J. K., van der Avoort, H. G. A. M.: Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992–93. Lancet 344 (1994) 665–670.

    Article  PubMed  CAS  Google Scholar 

  38. Melville-Smith, M., Saegroatt, V., Watkins, J.: A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralisation test in mice as a method for the estimation of tetanus antitoxin in human sera. J. Biol. Stand. 11 (1983) 137–144.

    Article  PubMed  CAS  Google Scholar 

  39. Camago, M. E., Silveira, L., Furuta, J. A., Oliveira, E. P. T., Germark O. A.: Immunoenzymatic assay of antidiphtheria toxin antibodies in human serum. J. Clin. Microbiol. 20 (1984) 772–774.

    Google Scholar 

  40. Grenier, B., Hamza, B., Biron, G., Xuref, C., Viarme, F., Roumantzeff, M.: Seroimmunity following vaccination in infants by an inactivated poliovirus preparation on Vero cells. Rev. Infect. Dis. 6 (Suppl. 2) (1984) 545–547.

    Google Scholar 

  41. Griffith, A. H.: The role of immunization in the control of diphtheria. Dev. Biol. Stand. 43 (1979) 3–13.

    PubMed  CAS  Google Scholar 

  42. Galazka, A. M.: The immunological basis for immunisation series. Module 3: Tetanus. WHO/EPI/GEN, Geneva 1993, p. 13.

    Google Scholar 

  43. Larsen, K., Ullberg-Ollsen, K., Ekwall, E., Heberstedt, B.: The immunisation of adults against diphtheria in Sweden. J. Biol. Stand. 15 (1987) 109–116.

    Article  PubMed  CAS  Google Scholar 

  44. Forrat, R., Dumas R., Seiberling, M., Merz, M., Lutsch, C., Lang, J.: Evaluation of the safety and pharmacokinetic profile of a new pasteurized human tetanus immunoglobulin by using a sham post-exposure prophylaxis of tetanus. Antimicrob. Agents Chemother. 42 (1998) 298–305.

    PubMed  CAS  Google Scholar 

  45. Vidor, E., Meschievitz, C., Plotkin, S.: Fiftten years of experience with Vero-produced enhanced potency inactivated poliovirus vaccine. Pediatr. Infect. Dis. J. 16 (1997) 312–322.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Development, Pasteur Mérieux Connaught, 3 avenue Pasteur, F-92430, Marnes-la-Coquette

    P. Laroche M.D., M. Barrand M. D. & S. C. Wood D. Phil

  2. Pasteur Mérieux MSD, La Halle Borie, Lyon

    K. Van Hasbrouck D. Pharm & L. Hessel M. D.

  3. Pasteur Mérieux Connaught, Lyon, France

    J. Lang M. D., Ph. D.

  4. Pasteur Mérieux MSD GmbH, Leimen, Germany

    E. Harzer M. D.

Authors
  1. P. Laroche M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Barrand M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. C. Wood D. Phil
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Van Hasbrouck D. Pharm
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Lang M. D., Ph. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. Harzer M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L. Hessel M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laroche, P., Barrand, M., Wood, S.C. et al. The immunogenicity and safety of a new combined diphtheria, tetanus and poliomyelitis booster vaccine (Td-eIPV). Infection 27, 49–56 (1999). https://doi.org/10.1007/BF02565175

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02565175

Keywords

Search

Navigation